The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature
Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199602000-00002 · Cited by 2,945
Self-citationProoxidant States and Tumor Promotion
Cerutti, P. A. (1985) · Science · doi:10.1126/science.2981433 · Cited by 2,497
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Conney, A. H. (1982) · PubMed · Cited by 1,557
Clinical importance of the cytochromes P450
Nebert, D. W., & Russell, D. W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11203-7 · Cited by 1,414
Self-citationInduction of phase I, II and III drug metabolism/transport by xenobiotics
Xu, C., Li, C. Y.-T., & Kong, A.-N. T. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977789 · Cited by 1,279
POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
Mahgoub, A., Dring, L. G., Idle, J. R., Lancaster, R., & Smith, R. L. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91430-1 · Cited by 1,183
Nebert, D. W., Dalton, T. P., Okey, A. B., & Gonzalez, F. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400004200 · Cited by 1,182
Self-citationImmune System Impairment and Hepatic Fibrosis in Mice Lacking the Dioxin-Binding Ah Receptor
Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S. T., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1995) · Science · doi:10.1126/science.7732381 · Cited by 1,075
Self-citationNelson, D. R., Zeldin, D. C., Hoffman, S. M., Maltais, L. J., Wain, H. M., & Nebert, D. W. (2004) · Pharmacogenetics · doi:10.1097/00008571-200401000-00001 · Cited by 1,027
Self-citationAnatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network
Bookout, A. L., Jeong, Y., Downes, M., Yu, R. T., Evans, R. M., & Mangelsdorf, D. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.049 · Cited by 1,015
Nebert, D. W., Roe, A. L., Dieter, M. Z., Solis, W. A., Yang, Y., & Dalton, T. P. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00310-x · Cited by 1,004
Self-citationLiver X receptors as integrators of metabolic and inflammatory signaling
Zelcer, N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27883 · Cited by 978
The P450 Gene Superfamily: Recommended Nomenclature
NEBERT, D. W., ADESNIK, M., COON, M. J., ESTABROOK, R. W., GONZALEZ, F. J., GUENGERICH, F. P., GUNSALUS, I. C., JOHNSON, E. F., KEMPER, B., LEVIN, W., et al. (1987) · DNA · doi:10.1089/dna.1987.6.1 · Cited by 818
Self-citationModulation of oestrogen receptor signalling by association with the activated dioxin receptor
Ohtake, F., Takeyama, K.-I., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., Tohyama, C., Krust, A., Mimura, J., Chambon, P., et al. (2003) · Nature · doi:10.1038/nature01606 · Cited by 798
Pharmacogenomics and Individualized Drug Therapy
Eichelbaum, M., Ingelman-Sundberg, M., & Evans, W. E. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104724 · Cited by 720
A New Cytochrome in Liver Microsomes
Omura, T., & Sato, R. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60338-2 · Cited by 684
Ingelman-Sundberg, M. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.007 · Cited by 676
Johansson, I., Lundqvist, E., Bertilsson, L., Dahl, M. L., Sjöqvist, F., & Ingelman-Sundberg, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11825 · Cited by 644
LXRS AND FXR: The Yin and Yang of Cholesterol and Fat Metabolism
Kalaany, N. Y., & Mangelsdorf, D. J. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.033104.152158 · Cited by 615
Cytochrome P450 and the Individuality of Species
Nelson, D. R. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1352 · Cited by 591
Cytochrome P450 pharmacogenetics and cancer
Rodriguez-Antona, C., & Ingelman-Sundberg, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209377 · Cited by 575
CHEK2 Is a Multiorgan Cancer Susceptibility Gene
Cybulski, C., Górski, B., Huzarski, T., Masojć, B., Mierzejewski, M., Dębniak, T., Teodorczyk, U., Byrski, T., Gronwald, J., Matyjasik, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/426403 · Cited by 551
Crabb, D. W., Matsumoto, M., Chang, D., & You, M. (2004) · Proceedings of the Nutrition Society · doi:10.1079/pns2003327 · Cited by 521
Genetic Engineering Using Homologous Recombination
Court, D. L., Sawitzke, J. A., & Thomason, L. C. (2002) · Annual Review of Genetics · doi:10.1146/annurev.genet.36.061102.093104 · Cited by 505
Hepatic uptake of chylomicron remnants
Cooper, A. D. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34932-4 · Cited by 499
At the Crossroads of Inflammation and Cancer
Clevers, H. (2004) · Cell · doi:10.1016/j.cell.2004.09.005 · Cited by 493
Modulation of paraoxonase (PON1) activity
Costa, L. G., Vitalone, A., Cole, T. B., & Furlong, C. E. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.08.027 · Cited by 488
Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy.
Guengerich, F. P. (1988) · PubMed · Cited by 455
The Ah Locus: Genetic Differences in Toxicity, Cancer, Mutation, and Birth Defects
Nebert, D. W. (1989) · Critical Reviews in Toxicology · doi:10.3109/10408448909017908 · Cited by 453
Self-citationButers, J. T. M., Sakai, S., Richter, T., Pineau, T., Alexander, D. L., Savas, U., Doehmer, J., Ward, J. M., Jefcoate, C. R., & Gonzalez, F. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1977 · Cited by 383
Metabolic oxidation phenotypes as markers for susceptibility to lung cancer
Ayesh, R., Idle, J. R., Ritchie, J. C., Crothers, M. J., & Hetzel, M. R. (1984) · Nature · doi:10.1038/312169a0 · Cited by 383
Discombe, G. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91898-4 · Cited by 376
Nioi, P., & Hayes, J. D. (2004) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.05.023 · Cited by 362
The role of the immune system in the pathophysiology of osteoporosis
Clowes, J. A., Riggs, B. L., & Khosla, S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00334.x · Cited by 359
Cigarette Smoking, N-Acetyltransferase 2 Genetic Polymorphisms, and Breast Cancer Risk
Ambrosone, C. B. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540180050032 · Cited by 343
Human Drug-Metabolizing Enzyme Polymorphisms: Effects on Risk of Toxicity and Cancer
NEBERT, D. W., MCKINNON, R. A., & PUGA, A. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.273 · Cited by 335
Self-citationPuga, A., Barnes, S. J., Dalton, T. P., Chang, C.-Y., Knudsen, E. S., & Maier, M. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2943 · Cited by 316
Self-citationUno, S., Dalton, T. P., Derkenne, S., Curran, C. P., Miller, M. L., Shertzer, H. G., & Nebert, D. W. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1225 · Cited by 316
Self-citationCytochrome P450 Gene Polymorphism and Cancer
Agundez, J. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335621 · Cited by 292
Nebert, D. W. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-9-1203 · Cited by 276
Self-citationEaton, D. L., Gallagher, E. P., Bammler, T. K., & Kunze, K. L. (1995) · Pharmacogenetics · doi:10.1097/00008571-199510000-00001 · Cited by 271
The mutagenic hazards of aquatic sediments: a review
Chen, G., & White, P. A. (2004) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2004.08.005 · Cited by 264
Kouri, R. E., McKinney, C. E., Slomiany, D. J., Snodgrass, D. R., Wray, N. P., & McLemore, T. L. (1982) · PubMed · Cited by 260
Pharmacokinetic variability of anticancer agents
Undevia, S. D., Gomez-Abuin, G., & Ratain, M. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1629 · Cited by 258
Grover, P. L., & Sims, P. H. (1968) · Biochemical Journal · doi:10.1042/bj1100159 · Cited by 257
Catalase enzyme mutations and their association with diseases
Góth, L., Rass, P., & Páy, A. (2004) · Molecular Diagnosis · doi:10.1007/bf03260057 · Cited by 238
Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist?
Nebert, D. W. (1997) · PubMed · Cited by 235
Self-citationStary, H. C. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90234-6 · Cited by 232
Glutathione conjugate mediated toxicities*1
Monks, T. J. (1990) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(90)90100-9 · Cited by 228
Uno, S., Dalton, T. P., Dragin, N., Curran, C. P., Derkenne, S., Miller, M. L., Shertzer, H. G., Gonzalez, F. J., & Nebert, D. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021501 · Cited by 227
Self-citationThe Toxicology of Hydroquinone — Relevance to Occupational and Environmental Exposure
DeCaprio, A. P. (1999) · Critical Reviews in Toxicology · doi:10.1080/10408449991349221 · Cited by 218
Geier, A., Dietrich, C. G., Voigt, S., Kim, S.-K., Gerloff, T., Kullak-Ublick, G. A., Lorenzen, J., Matern, S., & Gartung, C. (2003) · Hepatology · doi:10.1053/jhep.2003.50317 · Cited by 210
Drug-metabolizing enzymes in ligand-modulated transcription
Nebert, D. W. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90434-0 · Cited by 203
Self-citationNuclear Receptors and Drug Disposition Gene Regulation
Tirona, R. G., & Kim, R. B. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20324 · Cited by 192
Regulation of Hepatic Transporters by Xenobiotic Receptors
Klaassen, C., & Slitt, A. (2005) · Current Drug Metabolism · doi:10.2174/1389200054633826 · Cited by 186
Hein, D. W. (2006) · Oncogene · doi:10.1038/sj.onc.1209374 · Cited by 184
METABOLISM OF CONSTITUENT LIPIDS OF DOG CHYLOMICRONS*
Nestel, P. J., Havel, R. J., & Bezman, A. (1963) · Journal of Clinical Investigation · doi:10.1172/jci104815 · Cited by 184
8-Oxoguanine DNA damage: at the crossroad of alternative repair pathways
Fortini, P., Pascucci, B., Parlanti, E., D’Errico, M., Simonelli, V., & Dogliotti, E. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2003.07.004 · Cited by 181
Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids
Spiecker, M., & Liao, J. K. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.10.009 · Cited by 178
Oncogenic Signaling Pathways Activated in DMBA-Induced Mouse Mammary Tumors
Currier, N., Solomon, S. E., Demicco, E. G., Chang, D. L. F., Farago, M., Ying, H., Dominguez, I., Sonenshein, G. E., Cardiff, R. D., Xiao, Z.-X. J., et al. (2005) · Toxicologic Pathology · doi:10.1080/01926230500352226 · Cited by 174
CAR, The Continuously Advancing Receptor, in Drug Metabolism and Disease
Qatanani, M., & Moore, D. (2005) · Current Drug Metabolism · doi:10.2174/1389200054633899 · Cited by 169
Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse
Moriguchi, T., Motohashi, H., Hosoya, T., Nakajima, O., Takahashi, S., Ohsako, S., Aoki, Y., Nishimura, N., Tohyama, C., Fujii-Kuriyama, Y., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1037886100 · Cited by 164
Ye, Z., & Song, H. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.01.014 · Cited by 162
Oxidants and Signaling by Mitogen-Activated Protein Kinases in Lung Epithelium
Mossman, B. T., Lounsbury, K. M., & Reddy, S. P. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0047sf · Cited by 159
Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism.
Liang, H. C., Li, H., McKinnon, R. A., Duffy, J. J., Potter, S. S., Puga, A., & Nebert, D. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1671 · Cited by 159
Self-citationPharmacogenetics of human cytosolic sulfotransferases
Nowell, S., & Falany, C. N. (2006) · Oncogene · doi:10.1038/sj.onc.1209376 · Cited by 158
Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6.
Yu, A., Idle, J. R., Byrd, L. G., Krausz, K. W., Kupfer, A., & Gonzalez, F. J. (2003) · PubMed · doi:10.1097/01.fpc.0000054066.98065.7b · Cited by 158
Effects of dietary constituents on the metabolism of chemical carcinogens.
Wattenberg, L. W. (1975) · PubMed · Cited by 153
Landi, S., Gemignani, F., Moreno, V. R., Gioia‐Patricola, L., Chabrier, A., Guinó, E., Navarro, M., de, J., Capellá, G., & Canzian, F. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000165904.48994.3d · Cited by 150
Conney, A. H., Chang, R. L., Jerina, D. M., & Wei, S.-J. C. (1994) · Drug Metabolism Reviews · doi:10.3109/03602539409029788 · Cited by 146
SITES OF INITIAL REMOVAL OF CHYLOMICRON TRIGLYCERIDE FATTY ACIDS FROM THE BLOOD*
Nestel, P. J., Havel, R. J., & Bezman, A. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104648 · Cited by 145
The Evolution of Drug Metabolism
Nebert, D. W., & Dieter, M. Z. (2000) · Pharmacology · doi:10.1159/000028393 · Cited by 144
Self-citationProstaglandin E Synthase: A Novel Drug Target for Inflammation and Cancer
Murakami, M., & Kudo, I. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776055912 · Cited by 141
Pharmacogenomics and ???Individualized Drug Therapy???
Nebert, D. W., Jorge-Nebert, L. F., & Vesell, E. S. (2003) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200303060-00002 · Cited by 137
Self-citationLung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype
Hayes, R. B. (1990) · Lung Cancer · doi:10.1016/0169-5002(90)90270-v · Cited by 137
Role of polymorphic human cytochrome P450 enzymes in estrone oxidation
Cribb, A. E., Knight, M. J., Dryer, D., Guernsey, J., Hender, K., Tesch, M., & Saleh, T. M. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0801 · Cited by 118
Dalton, T. P., Dieter, M. Z., Matlib, R. S., Childs, N. L., Shertzer, H. G., Genter, M. B., & Nebert, D. W. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1913 · Cited by 115
Self-citationJansen, M. S., Nagel, S. C., Miranda, P. J., Lobenhofer, E. K., Afshari, C. A., & McDonnell, D. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402014101 · Cited by 107
Redox regulation of vascular prostanoid synthesis by the nitric oxide-superoxide system
Bachschmid, M. M., Schildknecht, S., & Ullrich, V. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.157 · Cited by 94
Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype
Jiang, Z., Dragin, N., Jorge-Nebert, L. F., Martin, M. V., Guengerich, F. P., Aklillu, E., Ingelman‐Sundberg, M., Hammons, G., Lyn‐Cook, B. D., Kadlubar, F. F., et al. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000204994.99429.46 · Cited by 93
Self-citationTerry, P., & Goodman, M. G. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0853 · Cited by 92
Plastaras, J. P., Guengerich, F. P., Nebert, D. W., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.11784 · Cited by 91
Self-citationToward a Molecular Basis of Alcohol Use and Abuse
Jansson, B., Jörnvall, H., Rydberg, U. S., Terenius, L. Y., & Vallée, B. L. (1994) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7330-7 · Cited by 90
GLUTATHIONE S-TRANSFERASE OMEGA 1 AND OMEGA 2 PHARMACOGENOMICS
Mukherjee, B., Salavaggione, O. E., Pelleymounter, L. L., Moon, I., Eckloff, B. W., Schaid, D. J., Wieben, E. D., & Weinshilboum, R. M. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009613 · Cited by 88
Polymorphism of UDP-Glucuronosyltransferase and Drug Metabolism
Maruo, Y., Iwai, M., Mori, A., Satō, H., & Takeuchi, Y. (2005) · Current Drug Metabolism · doi:10.2174/1389200053586064 · Cited by 84
EPHX1 Polymorphisms and the Risk of Lung Cancer
Kiyohara, C., Yoshimasu, K., Takayama, K., & Nakanishi, Y. (2005) · Epidemiology · doi:10.1097/01.ede.0000187627.70026.23 · Cited by 84
Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead
Nebert, D. W., & Vesell, E. S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.031 · Cited by 84
Self-citationJiang, Z., Dalton, T. P., Li, J., Wang, B., Tsuneoka, Y., Shertzer, H. G., Deka, R., & Nebert, D. W. (2005) · Human Mutation · doi:10.1002/humu.20134 · Cited by 81
Self-citationMicrosomal cytochrome P450 and eicosanoid metabolism
Capdevila, J. H., Harris, R. C., & Falck, J. R. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8466-y · Cited by 76
The BARD1 Cys557Ser Variant and Breast Cancer Risk in Iceland
Stacey, S., Sulem, P., Johannsson, O. T., Helgason, A., Guðmundsson, J., Kostic, J. P., Kristjánsson, K., Jonsdottir, T. E., Sigurdsson, H., Hrafnkelsson, J., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030217 · Cited by 75
The Aryl Hydrocarbon Receptor Predisposes Hepatocytes to Fas-Mediated Apoptosis
Park, K., Mitchell, K. A., Huang, G., & Elferink, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.005223 · Cited by 69
Liver Deformation in Ahr-Null Mice: Evidence for Aberrant Hepatic Perfusion In Early Development
Harstad, E. B., Guite, C. A., Thomae, T. L., & Bradfield, C. A. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020107 · Cited by 67
Role of TGFβ in skin inflammation and carcinogenesis
Li, A. G., Lu, S., Han, G., Hoot, K. E., & Wang, X. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20229 · Cited by 60
McCollum Award Lecture, 1992: Vitamin A absorption, transport, cellular uptake, and storage
Norum, K., & Blomhoff, R. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.4.735 · Cited by 60
Dragin, N., Dalton, T. P., Miller, M. L., Shertzer, H. G., & Nebert, D. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601159200 · Cited by 56
Self-citationBiological Reactive Intermediates that Mediate Chromium (VI) Toxicity
Pourahmad, J., & O’Brien, P. J. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0667-6_27 · Cited by 52
Hishida, A., Terakura, S., Emi, N., Yamamoto, K., Murata, M., Nishio, K., Sekido, Y., Niwa, T., Hamajima, N., & Naoe, T. (2005) · PubMed · Cited by 45
THE METABOLISM OF CERTAIN DRUGS AND FOOD CHEMICALS IN MAN*
Williams, R. T. (1971) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1971.tb46896.x · Cited by 41
The role of glutathione reductase in the cytotoxicity of chromium (VI) in isolated rat hepatocytes
Gunaratnam, M., & Grant, M. H. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(01)00153-3 · Cited by 39
Does G6PD deficiency protect against cancer? A critical review.
Cocco, P. (1987) · Journal of Epidemiology & Community Health · doi:10.1136/jech.41.2.89 · Cited by 36
Díaz‐Cruz, E. S., & Brueggemeier, R. W. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006776930873 · Cited by 36
Polymorphisms of human nuclear receptors that control expression of drug-metabolizing enzymes
Okey, A. B., Boutros, P. C., & Harper, P. A. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200506000-00001 · Cited by 35
Derkenne, S., Curran, C. P., Shertzer, H. G., Dalton, T. P., Dragin, N., & Nebert, D. W. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000167326.00411.50 · Cited by 34
Self-citationInter-individual susceptibility to environmental toxicants—A current assessment
Nebert, D. W. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.01.043 · Cited by 28
Self-citationKakizaki, S., Karami, S., & Negishi, M. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.2.208 · Cited by 22
Reductive Activation Of Cr(Vi) By Nitric Oxide Synthase
Porter, R., Jáchymová, M., Pavel Martasek, E., Kalyanaraman, B., & Vasquez-Vivar, J. M. (2005) · Chemical Research in Toxicology · doi:10.1021/tx049778e · Cited by 18
Mannering, G. J., Shoeman, J. A., & Deloria, L. B. (1992) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08558-7 · Cited by 17
Ramakrishna, G. (1998) · Carcinogenesis · doi:10.1093/carcin/19.3.463 · Cited by 15
Parmentier, J., Lavrentyev, E. N., Falck, J. R., Capdevila, J. H., & Malik, K. U. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.03.002 · Cited by 12
Metabolic susceptibility to agricultural pesticides and non-Hodgkin's lymphoma.
Schroeder, J. C. (2005) · PubMed · Cited by 8
Cited by
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
Eicosanoid storm in infection and inflammation
Dennis, E. A., & Norris, P. C. (2015) · Nature Reviews Immunology · doi:10.1038/nri3859 · Cited by 1,517
Genome-wide association study identifies eight loci associated with blood pressure
Wellcome Trust Case Control Consortium, Newton-Cheh, C., Johnson, T., Gateva, V., Tobin, M. D., Bochud, M., Coin, L., Najjar, S. S., Zhao, J. H., Heath, S. C., et al. (2009) · Nature Genetics · doi:10.1038/ng.361 · Cited by 1,215
Stimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
Inhibition and induction of human cytochrome P450 enzymes: current status
Pelkonen, O., Turpeinen, M., Hakkola, J., Honkakoski, P., Hukkanen, J., & Raunio, H. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0332-8 · Cited by 569
Metadata
- Authors
- Nebert, D. W., & Dalton, T. P.
- Venue
- Nature Reviews Cancer
- Published
- 2006-12-01
- Volume
- 6
- Issue
- 12
- Pages
- 947-960
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2072145718
- Cited by
- 958
- References
- 114
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.